2m 2m 2m 2m 2m 2m 2m
DENTSPLY SIRONA (XRAY)
NASDAQ
$10.23+$0.08 (+0.79%)
Price as of Jun 23, 2026 7:56 PM EDT- $2.0BMarket Cap
- -31.93%1-Year Change
- Medical Instruments & SuppliesIndustry
DENTSPLY SIRONA (XRAY)
$10.23+$0.08 (+0.79%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 3.7B -2.98% | 3.8B -4.34% | 4.0B +1.10% | 3.9B -7.30% | |
Cost of Revenue | 1.8B +0.27% | 1.8B -2.34% | 1.9B +4.68% | 1.8B -4.72% | |
Gross Profit | 1.8B -6.03% | 2.0B -6.14% | 2.1B -1.93% | 2.1B -9.37% | |
Sales and Marketing Expense | 1.4B -10.40% | 1.6B -0.50% | 1.6B +1.51% | 1.6B +2.45% | |
Research and Development Expense | -150.0M -9.09% | -165.0M -10.33% | -184.0M +5.75% | -174.0M +1.75% | |
Depreciation and Amortization Expense | 211.0M -2.31% | 216.0M +2.37% | 211.0M +0.96% | 209.0M -5.86% | |
Total Operating Expenses | 1.8B +0.27% | 1.8B -2.34% | 1.9B +4.68% | 1.8B -4.72% | |
Operating Profit | -422.0M -51.99% | -879.0M +934.12% | -85.0M -90.93% | -937.0M -254.11% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | -3.0M -96.30% | -81.0M +35.00% | -60.0M +9.09% | |
Interest Income and Expense and Net | 0 +100.00% | -3.0M -96.30% | -81.0M +35.00% | -60.0M +9.09% | |
Total Nonoperating Income and Expense | 24.0M +100.00% | 12.0M +233.33% | -9.0M -84.48% | -58.0M +625.00% | |
Income before Taxes | -486.0M -48.08% | -936.0M +434.86% | -175.0M -83.41% | -1.1B -293.58% | |
Income Taxes | 112.0M +530.77% | -26.0M -39.53% | -43.0M -59.05% | -105.0M -178.36% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -598.0M -34.29% | -910.0M +589.39% | -132.0M -86.11% | -950.0M -331.14% | |
Net Income from Continuing Operations Applicable to Common | -486.0M -48.08% | -936.0M +434.86% | -175.0M -83.41% | -1.1B -293.58% | |
Basic EPS and Net Income | -3.00 -33.04% | -4.48 +622.58% | -0.62 -85.94% | -4.41 -334.57% | |
Diluted EPS and Net Income | -3.00 -33.04% | -4.48 +622.58% | -0.62 -85.94% | -4.41 -335.83% | |
Basic Weighted Average Shares | 199.4M -1.87% | 203.2M -4.15% | 212.0M -1.62% | 215.5M -1.33% | |
Diluted Weighted Average Shares | 199.4M -1.87% | 203.2M -4.15% | 212.0M -1.62% | 215.5M -2.13% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 326.0M +19.85% | 272.0M -18.56% | 334.0M -8.49% | 365.0M +7.67% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 326.0M +19.85% | 272.0M -18.56% | 334.0M -8.49% | 365.0M +7.67% | |
Total Current Assets | 2.0B +15.86% | 1.7B -11.51% | 2.0B +4.23% | 1.9B +2.21% | |
Accumulated Depreciation | 1.6B +17.23% | 1.3B -1.76% | 1.4B +4.04% | 1.3B +0.31% | |
Property and Plant and Equipment and Net | 861.0M +12.40% | 766.0M -4.25% | 800.0M +5.12% | 761.0M -1.55% | |
Total Long-Term Assets | 284.0M -5.65% | 301.0M +9.06% | 276.0M +39.39% | 198.0M +63.64% | |
Total Assets | 5.4B -5.63% | 5.8B -21.94% | 7.4B -3.57% | 7.6B -17.27% | |
Income Taxes Payable | 124.0M -28.74% | 174.0M -37.18% | 277.0M -16.82% | 333.0M -25.67% | |
Total Short-Term Debt | 313.0M -42.99% | 549.0M +70.50% | 322.0M +172.88% | 118.0M -35.16% | |
Total Current Liabilities | 1.3B -15.48% | 1.6B +11.51% | 1.4B +21.79% | 1.2B -7.22% | |
Total Long-Term Debt | 2.0B +27.05% | 1.6B -11.69% | 1.8B -1.64% | 1.8B -4.55% | |
Total Long-Term Liabilities | 544.0M +31.08% | 415.0M -17.33% | 502.0M +25.81% | 399.0M -24.43% | |
Total Liabilities | 4.1B +7.32% | 3.8B -6.53% | 4.1B +6.40% | 3.8B -9.69% | |
Retained Earnings | -1.6B +87.31% | -835.0M -507.32% | 205.0M -55.04% | 456.0M -69.88% | |
Total Stockholders Equity | 1.3B -31.05% | 1.9B -41.03% | 3.3B -13.59% | 3.8B -23.72% | |
Total Shares Outstanding | 199.6M +0.40% | 198.8M -4.05% | 207.2M -3.76% | 215.3M -0.97% | |
Cash Flow | |||||
Cash from Operating Activities | 235.0M -49.02% | 461.0M +22.28% | 377.0M -27.08% | 517.0M -21.31% | |
Capital Expenditures | 131.0M -27.22% | 180.0M +20.81% | 149.0M 0.00% | 149.0M +4.93% | |
Cash from Investing Activities | -132.0M -32.99% | -197.0M +121.35% | -89.0M -35.51% | -138.0M -61.45% | |
Dividends Paid | 128.0M +1.59% | 126.0M +8.62% | 116.0M +11.54% | 104.0M +13.04% | |
Cash from Financing Activities | -80.0M -73.51% | -302.0M -1.63% | -307.0M -6.69% | -329.0M -13.19% | |
Financials Ratio | |||||
Gross Margin | 50.00% -3.14% | 51.62% -1.88% | 52.61% -2.99% | 54.23% -2.23% | |
Operating Margin | -11.47% -50.52% | -23.17% +980.99% | -2.14% -91.03% | -23.89% -266.25% | |
Return on Assets | -10.70% -22.88% | -13.87% +688.67% | -1.76% -84.38% | -11.25% -354.40% | |
Return on Equity | -36.45% +4.85% | -34.77% +835.53% | -3.72% -82.77% | -21.57% -361.48% | |
Revenue Growth | -2.98% -31.32% | -4.34% -495.66% | 1.10% +115.01% | -7.30% -127.45% | |
Current Ratio | 1.51 +37.09% | 1.10 -20.64% | 1.38 -14.42% | 1.62 +10.16% | |
Cash Ratio | 0.24 +41.76% | 0.17 -26.96% | 0.23 -24.87% | 0.31 +16.07% | |
Debt-to-Equity Ratio | 1.74 +58.14% | 1.10 +70.93% | 0.64 +26.09% | 0.51 +21.66% | |
Debt-to-Assets Ratio | 0.43 +15.55% | 0.37 +29.12% | 0.29 +12.97% | 0.25 +12.17% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow